{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:46:28Z","timestamp":1793810788672,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.joms.2020.12.045","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:43:41Z","timestamp":1610066621000},"page":"1683-1688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Factors Influencing Severity of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7974-996X","authenticated-orcid":false,"given":"Zhiqiang","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2020.12.045_bib1","first-page":"2014","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"1938","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijom.2015.01.014","article-title":"Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: A multivariate analysis","volume":"44","author":"Nisi","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib3","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.joms.2009.04.067","article-title":"Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Kwon","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.oraloncology.2008.01.012","article-title":"Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates","volume":"44","author":"Bagan","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2020.12.045_bib5","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.ijom.2020.05.011","article-title":"Combined reconstruction plate fixation and submandibular gland translocation for the management of medication-related osteonecrosis of the mandible","volume":"49","author":"Zhou","year":"2020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib6","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1080\/10428194.2017.1300889","article-title":"Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy","volume":"58","author":"Kastritis","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.joms.2020.12.045_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12967-015-0568-z","article-title":"Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw","volume":"13","author":"Kalyan","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.joms.2020.12.045_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.breast.2010.03.008","article-title":"Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment","volume":"19","author":"Fusco","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.joms.2020.12.045_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/ol.2015.3156","article-title":"Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws","volume":"10","author":"Gunaldi","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.joms.2020.12.045_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.oooo.2018.02.010","article-title":"Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw","volume":"125","author":"Higuchi","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2020.12.045_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oooo.2017.09.014","article-title":"Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab","volume":"125","author":"Yarom","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2020.12.045_bib12","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1097\/MD.0000000000000671","article-title":"Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment?","volume":"94","author":"Pilanci","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.joms.2020.12.045_bib13","first-page":"e342","article-title":"A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors","volume":"22","author":"Manfredi","year":"2017","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.joms.2020.12.045_bib14","doi-asserted-by":"crossref","first-page":"e0201343","DOI":"10.1371\/journal.pone.0201343","article-title":"Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?","volume":"13","author":"Soutome","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.joms.2020.12.045_bib15","first-page":"e26","article-title":"Biomarkers to predict the onset of biphosphonate-related osteonecrosis of the jaw: A systematic review","volume":"24","author":"Lorenzo-Pouso","year":"2018","journal-title":"Medicina Oral Patolog\u00eda Oral y Cirugia Bucal"},{"key":"10.1016\/j.joms.2020.12.045_bib16","first-page":"e542","article-title":"Serum levels of RANKL and OPG, and the RANKL\/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?","volume":"22","author":"Bagan","year":"2017","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.joms.2020.12.045_bib17","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.2217\/fon-2019-0352","article-title":"Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment","volume":"15","author":"Qi","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.joms.2020.12.045_bib18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.joms.2020.12.045_bib19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2020.12.045_bib20","first-page":"2007","article-title":"A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients","volume":"18","author":"Jadu","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.joms.2020.12.045_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10006-018-0688-8","article-title":"Low-dose methotrexate in rheumatoid arthritis: A potential risk factor for bisphosphonate-induced osteonecrosis of the jaw","volume":"22","author":"Mathai","year":"2018","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: Position paper 2017 of the Japanese Allied Committee on osteonecrosis of the jaw","volume":"35","author":"Yoneda","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.joms.2020.12.045_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2020.12.045_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5125\/jkaoms.2016.42.4.193","article-title":"Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies","volume":"42","author":"Kim","year":"2016","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12992","article-title":"Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series","volume":"25","author":"Aljohani","year":"2019","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2020.12.045_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.joms.2020.12.045_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcms.2018.03.005","article-title":"Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - a single center cohort study","volume":"46","author":"Ristow","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib28","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jcms.2016.08.001","article-title":"Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws","volume":"44","author":"Klingelhoffer","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib29","doi-asserted-by":"crossref","first-page":"8345309","DOI":"10.1155\/2019\/8345309","article-title":"Medication-related osteonecrosis of the jaws: Two center retrospective cohort studies","volume":"2019","author":"Petrovic","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.joms.2020.12.045_bib30","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/hed.23235","article-title":"Factors predicting the prognosis of oral alendronate-related osteonecrosis of the jaws: A 4-year cohort study","volume":"35","author":"Lee","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2020.12.045_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.12.045_bib32","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpedi.161.11.1048","article-title":"Hypoalbuminemia in critically ill children","volume":"116","author":"Horowitz","year":"2007","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120315433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120315433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:05:03Z","timestamp":1759511103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239120315433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0278239120315433"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2020.12.045","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Influencing Severity of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2020.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}